Psych Congress October 1 - 2024 Supporting materials POSTER: CT-152, a Prescription Digital Therapeutic for Major Depressive Disorder: A Real-World Analysis of Durability of Treatment Effect POSTER: Relative Efficacy and Safety of Adjunctive CT-152 in Patients with Major Depressive Disorder (MDD): Systematic Review and Network Meta-Analysis POSTER: Safety and Efficacy of Aripiprazole Once-Monthly Maintenance Treatment in Black/African American Adults Diagnosed With Bipolar I Disorder: A Post-hoc Analysis of Data From a 52 Week, Open-Label Study POSTER: A Prescription Digital Therapeutic, CT-152, for Treating Major Depressive Disorder: Effectiveness and Safety Results of the Mirai Randomized Controlled Trial POSTER: Comparative Efficacy and Safety of Adjunctive CT-152 in Patients with Major Depressive Disorder: A Network Meta-Regression POSTER: Adherence and Engagement Metrics With the Novel Prescription Digital Therapeutic, CT-152 POSTER: Emotional Faces Memory Task Performance and Clinical Outcomes for the Novel Prescription Digital Therapeutic, CT-152 POSTER: A Qualitative, Interview-based Study of Patient, Caregiver, and Prescriber Preferences for a Long-acting Injectable Antipsychotic Formulation Administered Once Every 2 Months for Schizophrenia or Bipolar I Disorder POSTER: The Impact of Aripiprazole Once-Monthly Initiation and Persistence on Concomitant Psychiatric Medications in Adults Diagnosed With Bipolar I Disorder: A Retrospective Analysis of Claims Data From the United States POSTER: The Effect of Early Initiation of Aripiprazole Once-Monthly 400 mg on Healthcare Resource Utilization and Healthcare Costs in Patients Diagnosed with Bipolar I Disorder: Real-World Evidence from US Claims Data